Chama MA, Onyame HA, Fleischer C, Osei-Safo D, Waibel R, Otchere J, Addae-Mensah I, Wilson M (2020)
Publication Type: Journal article
Publication year: 2020
Book Volume: 6
Article Number: e04460
Journal Issue: 7
DOI: 10.1016/j.heliyon.2020.e04460
Dichapetalum crassifolium Chodat (Dichapetalaceae) is widely distributed in Africa, Tropical Asia and Latin America. As part of our quest for potential bioactive lead compounds for various neglected tropical diseases, we report the anti-schistosomal potential of the crude extracts and chemical constituents of the stems and roots of Dichapetalum crassifolium. Column chromatography of extracts of the stems and roots led to the isolation and identification of three oleanane-type triterpenoids, friedelan-3β-ol (1), friedelan-3-one (2), and maslinic acid (3); the ursane-type tritepenoid, pomolic acid (4) and the dammarane-type tetracyclic triterpenoids, dichapetalin A (5) and dichapetalin M (6). Dichapetalin A was isolated from only the roots. Isolated compounds were identified by comparison of their physico-chemical and spectral data with published data. The highest in vitro anti-schistosomal activity (IC
APA:
Chama, M.A., Onyame, H.A., Fleischer, C., Osei-Safo, D., Waibel, R., Otchere, J.,... Wilson, M. (2020). In vitro activities of crude extracts and triterpenoid constituents of Dichapetalum crassifolium Chodat against clinical isolates of Schistosoma haematobium. Heliyon, 6(7). https://dx.doi.org/10.1016/j.heliyon.2020.e04460
MLA:
Chama, Mary Anti, et al. "In vitro activities of crude extracts and triterpenoid constituents of Dichapetalum crassifolium Chodat against clinical isolates of Schistosoma haematobium." Heliyon 6.7 (2020).
BibTeX: Download